At the very junction of public health lies the pharmaceutical sector. It is essential to examine the effects of regulations and market structure in line with competition law aspects. Therefore, this study aims to look into the extent and impact of the pharmaceutical sector practices and trends onto the consumers especially at a retail level in the Bengaluru region. How local market dynamics and regulatory weakness have led to price distortion and reduced access to medicine which overall harms an innocent and uninformed consumer. Using a mixed and interactive approach of combining empirically accessed and doctrinally analysed data to assess the impact on consumers. This study draws its conclusions from a structured survey of pharmacies and consumers, including 15 outlets and 35 consumers. The Competition Act of 2002 and the DPCO of 1995 along with landmark cases like Novartis AG v Union of India (2013) have been relied on. Additionally, reliance has been placed on Indias situation within the global discussion on pharmaceutical competition policy. The studies have revealed brand favoritism, entry barriers, and limiting of consumer choices. Significant gaps in the legal framework have been strawed out and inclusion of stronger enforcement measures by CCI is recommended for transparency.